RenBio

0 followers


RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA bluep... Read more

Employees

11-50

Links

Org chart

Co-Founders

Collapse
Rachel A. Liberatore
President & Chief Scientific Officer
Marek M. Drozdz
Director of Research
Annelyn P. O’Rourke
Director of Finance & Human Resources
Robert Miller
Director of Development
Andy T. Thompson
Lab Manager
Krystal Ramos
Executive Assistant

Teams

This company has no teams yet